The health effects of electronic cigarettes

New England Journal of Medicine

Volumn 375, Issue 14, 2016, Pages 1372-1381

  Dinakar, Chitra ^a   O'Connor, George T ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; AMFEBUTAMONE; CARCINOGEN; FLAVORING AGENT; FORMALDEHYDE; GLUTATHIONE; NICOTINE; PLACEBO; TOBACCO SMOKE; VARENICLINE; AEROSOL; AIR POLLUTANT;

AEROSOL; AGE DISTRIBUTION; ALLERGIC AIRWAY INFLAMMATION; ASTHMA; BLOOD CELL COUNT; CLINICAL EFFECTIVENESS; DIRECT-TO-CONSUMER ADVERTIZING; DIZZINESS; ELECTRIC POTENTIAL; ELECTRONIC CIGARETTE; EMBRYO DEATH; FOOD AND DRUG ADMINISTRATION; GRANULOCYTE; HEADACHE; HEALTH IMPACT ASSESSMENT; HEART FAILURE; HEART INFARCTION; HIGH SCHOOL STUDENT; HUMAN; IN VITRO STUDY; INTERNET; LEUKOCYTE; LIQUID; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; NEUROTOXICITY; NICOTINE REPLACEMENT THERAPY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PNEUMONIA; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; RESPIRATORY EPITHELIUM; REVIEW; RISK REDUCTION; SAFETY; SMOKING; SMOKING CESSATION; SOCIAL MEDIA; STAPHYLOCOCCUS INFECTION; TELEVISION; VOMITING; ADVERSE EFFECTS; AIR POLLUTANT; ANIMAL; CHEMISTRY;

AEROSOLS; AIR POLLUTANTS; ANIMALS; ELECTRONIC CIGARETTES; HUMANS; NICOTINE;

EID: 84990049872     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1502466     Document Type: Review

References (86)

1. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014; 5: 67-86.
2. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res 2015; 17: 175-9.
3. Zhu SH, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; 23: Suppl 3: iii3-9.
4. Green SH, Bayer R, Fairchild AL. Evidence, policy, and e-cigarettes - will England reframe the debate? N Engl J Med 2016; 374: 1301-3.
5. Fairchild AL, Bayer R. Public health: smoke and fire over e-cigarettes. Science 2015; 347: 375-6.
6. McMillen RC, Gottlieb MA, Shaefer RM, Winickoff JP, Klein JD. Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res 2015; 17: 1195-202.
7. Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M. Electronic cigarette use by college students. Drug Alcohol Depend 2013; 131: 214-21.
8. Cummins SE, Zhu SH, Tedeschi GJ, Gamst AC, Myers MG. Use of e-cigarettes by individuals with mental health conditions. Tob Control 2014; 23: Suppl 3: iii48-53.
9. Bunnell RE, Agaku IT, Arrazola RA, et al. Intentions to smoke cigarettes among never-smoking US middle and high school electronic cigarette users: National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res 2015; 17: 228-35.
10. Singh T, Arrazola RA, Corey CG, et al. Tobacco use among middle and high school students - United States, 2011-2015. MMWR Morb Mortal Wkly Rep 2016; 65: 361-7.
11. Leventhal AM, Strong DR, Kirkpatrick MG, et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 2015; 314: 700-7.
12. Paek HJ, Kim S, Hove T, Huh JY. Reduced harm or another gateway to smoking? Source, message, and information characteristics of e-cigarette videos on YouTube. J Health Commun 2014; 19: 545-60.
13. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics 2015; 135(1): e43-51.
14. Singh T, Agaku I, Arrazola R, et al. Exposure to advertisements and electronic cigarette use among US middle and high school students. Pediatrics 2016 May 25 (Epub ahead of print).
15. Wahba P. U.S. e-cigarette sales seen rising 24.2% per year through 2018. Fortune. June 10, 2014 (http://fortune .com/ 2014/ 06/ 10/ e-cigarette-sales-rising/ ).
16. Herzog B, Gerberi J. E-cigs revolutionizing the tobacco industry. Wells Fargo Securities, June 12, 2013 (http://www .smallcapfinancialwire .com/ wp-content/ uploads/ 2013/ 11/ E-Cigs-Revolutionizing -the-Tobacco-Industry-Interactive-Model .pdf).
17. Adkison SE, O'Connor RJ, Bansal- Travers M, et al. Electronic nicotine delivery systems: International Tobacco Control Four-Country Survey. Am J Prev Med 2013; 44: 207-15.
18. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109: 1531-40.
19. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health 2013; 103: 923-30.
20. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med 2014; 174: 812-3.
21. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013; 8(6): e66317.
22. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 2014; 11: 11220-48.
23. Tseng TY, Ostroff JS, Campo A, et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob Res 2016 January 17 (Epub ahead of print).
24. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629-37.
25. McRobbie H, Bullen C, Hartmann- Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014; 12: CD010216.
26. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4: 116-28.
27. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One 2015; 10(3): e0122544.
28. Renne RA, Wehner AP, Greenspan BJ, et al. 2-Week and 13-week inhalation studies of aerosolized glycerol in rats. Inhal Toxicol 1992; 4: 95-111.
29. Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy SM. Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med 2005; 47: 411-8.
30. Varlet V, Farsalinos K, Augsburger M, Thomas A, Etter JF. Toxicity assessment of refill liquids for electronic cigarettes. Int J Environ Res Public Health 2015; 12: 4796-815.
31. Oh JA, Shin HS. Identification and quantification of several contaminated compounds in replacement liquids of electronic cigarettes by gas chromatographymass spectrometry. J Chromatogr Sci 2015; 53: 841-8.
32. Lisko JG, Tran H, Stanfill SB, Blount BC, Watson CH. Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in e-cigarette cartridges and refill solutions. Nicotine Tob Res 2015; 17: 1270-8.
33. Geiss O, Bianchi I, Barahona F, Barrero- Moreno J. Characterisation of mainstream and passive vapours emitted by selected electronic cigarettes. Int J Hyg Environ Health 2015; 218: 169-80.
34. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23: 133-9.
35. Farsalinos KE, Voudris V, Poulas K. Are metals emitted from electronic cigarettes a reason for health concern? A riskassessment analysis of currently available literature. Int J Environ Res Public Health 2015; 12: 5215-32.
36. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8(3): e57987.
37. Lerner CA, Sundar IK, Watson RM, et al. Environmental health hazards of e-cigarettes and their components: oxidants and copper in e-cigarette aerosols. Environ Pollut 2015; 198: 100-7.
38. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol 2014; 88: 1295-308.
39. Tierney PA, Karpinski CD, Brown JE, Luo W, Pankow JF. Flavour chemicals in electronic cigarette fluids. Tob Control 2016; 25(e1): e10-5.
40. Farsalinos KE, Kistler KA, Gillman G, Voudris V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res 2015; 17: 168-74.
41. Barrington-Trimis JL, Samet JM, McConnell R. Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA 2014; 312: 2493-4.
42. Farsalinos KE, Gillman IG, Melvin MS, et al. Nicotine levels and presence of selected tobacco-derived toxins in tobacco flavoured electronic cigarette refill liquids. Int J Environ Res Public Health 2015; 12: 3439-52.
43. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16: 1319-26.
44. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372: 392-4.
45. Nitzkin JL, Farsalinos K, Siegel M. More on hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372: 1575.
46. Misra M, Leverette RD, Cooper BT, Bennett MB, Brown SE. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 2014; 11: 11325-47.
47. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 2014; 9(9): e108342.
48. Willershausen I, Wolf T, Weyer V, Sader R, Ghanaati S, Willershausen B. Influence of e-smoking liquids on human periodontal ligament fibroblasts. Head Face Med 2014; 10: 39.
49. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34: 529-37.
50. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013; 25: 354-61.
51. Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013; 10: 5146-62.
52. Rubenstein DA, Hom S, Ghebrehiwet B, Yin W. Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. Mol Immunol 2015; 67: 2 Pt B: 652-60.
53. Cervellati F, Muresan XM, Sticozzi C, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro 2014; 28: 999-1005.
54. Neilson L, Mankus C, Thorne D, Jackson G, DeBay J, Meredith C. Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue: application for assess- ment of e-cigarette aerosol. Toxicol In Vitro 2015; 29: 1952-62.
55. Scheffler S, Dieken H, Krischenowski O, Forster C, Branscheid D, Aufderheide M. Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 2015; 12: 3915-25.
56. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med 2016; 94: 667-79.
57. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015; 309: L175-87.
58. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015; 10(2): e0116732.
59. Husari A, Shihadeh A, Talih S, Hashem Y, El Sabban M, Zaatari G. Acute exposure to electronic and combustible cigarette aerosols: effects in an animal model and in human alveolar cells. Nicotine Tob Res 2016; 18: 613-9.
60. Lim HB, Kim SH. Inhallation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice. Toxicol Res 2014; 30: 13-8.
61. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 2015; 10(2): e0116861.
62. McGrath-Morrow SA, Hayashi M, Aherrera A, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One 2015; 10(2): e0118344.
63. Palpant NJ, Hofsteen P, Pabon L, Reinecke H, Murry CE. Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS One 2015; 10(5): e0126259.
64. Vakkalanka JP, Hardison LS Jr, Holstege CP. Epidemiological trends in electronic cigarette exposures reported to U.S. poison centers. Clin Toxicol (Phila) 2014; 52: 542-8.
65. Ordonez JE, Kleinschmidt KC, Forrester MB. Electronic cigarette exposures reported to Texas poison centers. Nicotine Tob Res 2015; 17: 209-11.
66. Kim JW, Baum CR. Liquid nicotine toxicity. Pediatr Emerg Care 2015; 31: 517-21.
67. Chen BC, Bright SB, Trivedi AR, Valento M. Death following intentional ingestion of e-liquid. Clin Toxicol (Phila) 2015; 53: 914-6.
68. Roger JM, Abayon M, Elad S, Kolokythas A. Oral trauma and tooth avulsion following explosion of e-cigarette. J Oral Maxillofac Surg 2016; 74: 1181-5.
69. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83: 531-41.
70. Republished from Drug and Therapeutics Bulletin: nicotine and health. BMJ 2014; 349: 2014.7.0264rep.
71. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009; 338: b1024.
72. Lee PN. Epidemiological evidence relating snus to health - an updated review based on recent publications. Harm Reduct J 2013; 10: 36.
73. The health consequences of smoking - 50 years of progress: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, 2014.
74. Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther 2009; 122: 125-39.
75. England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 2015; 49: 286-93.
76. Cooper S, Taggar J, Lewis S, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, doubleblind, placebo-controlled SNAP trial. Lancet Respir Med 2014; 2: 728-37.
77. Kandel ER, Kandel DB. Shattuck Lecture - a molecular basis for nicotine as a gateway drug. N Engl J Med 2014; 371: 932-43.
78. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol 2015; 71: 24-34.
79. Farsalinos K, Cibella F, Caponnetto P, et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med 2016; 11: 85-94.
80. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotinedelivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014; 14: 78.
81. Szołtysek-Bołdys I, Sobczak A, Zielińska-Danch W, Bartoń A, Koszowski B, Kośmider L. Influence of inhaled nicotine source on arterial stiffness. Przegl Lek 2014; 71: 572-5.
82. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141: 1400-6.
83. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013; 25: 91-101.
84. Polosa R, Morjaria JB, Caponnetto P, et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med 2016; 21: 99-108.
85. Flouris AD, Poulianiti KP, Chorti MS, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012; 50: 3600-3.
86. Farber HJ, Walley SC, Groner JA, Nelson KE, Section on Tobacco Control. Clinical practice policy to protect children from tobacco, nicotine, and tobacco smoke. Pediatrics 2015; 136: 1008-17.